Search

everythinglearnresearchcommunity

for

Search:↓

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Men with male pattern baldness are more likely to have benign prostatic hyperplasia.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Drospirenone can hide symptoms of certain hormonal disorders, complicating diagnosis.

Men with benign prostate hyperplasia have more meibomian gland loss and tear film problems.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

A patient with untreated congenital adrenal hyperplasia had large benign tumors in her adrenal glands removed, improving her symptoms.

The patient with severe hirsutism improved after being diagnosed with non-classic congenital adrenal hyperplasia and treated with corticosteroids.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Increasing COX-2 in mouse skin causes bigger sebaceous glands and thinner hair, but stopping COX-2 can reverse hair thinning.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Hyaluronic acid filler and fat grafting can cause rare skin complications.

Removing PLCg1 from skin cells caused thicker oil glands and less hair in mice.

Congenital Adrenal Hyperplasia is mainly caused by enzyme deficiencies, leading to varying symptoms like hormone imbalances and physical changes.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Urinary PSA could be an early marker for enlarged prostate.

A patient with congenital adrenal hyperplasia improved after adjusting her medication to prevent Cushing's syndrome symptoms.

Nonclassic congenital adrenal hyperplasia is a common genetic disorder that can cause a range of symptoms and requires personalized treatment.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Hair loss linked to prostate enlargement; stress and family history important factors.

There is no link between hair loss and prostate enlargement.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.